For Fragments Based Innovations
 
 
 
 
Products
Rare Organics
Structure Product Information
GLU008
D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-
[842133-18-0]
GLU013
L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-
[137281-23-3]
Disodium [150399-23-8]
GLU014
(3R,4S,5R,6R)-6-(acetoxymethyl)-2-(3-(5-(4-fluorophenyl)thiophene-2-carbonyl)-4-methylphenyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate
[1312810-97-1]
GLU015
-D-Glucofuranose, 1,2:5,6-bis-O-(1-methylethylidene)-
[582-52-5]
GLU016
-D-Glucopyranose, 1,2,3,4,6-pentakis(2,2-dimethylpropanoate)
[81058-26-6]
GLU017
-D-Glucopyranose, 1,2,3,4,6-pentakis(2,2-dimethylpropanoate)
[1213234-53-7]
GLU018
-D-Glucopyranosyl bromide, 2,3,4,6-tetrakis(2,2-dimethylpropanoate)
[81058-27-7]
GLY001
-D-glycero-D-galacto-non-2-enonic acid, 5-(acetylamino)-2,6-anhydro-4-azido-3,4,5-trideoxy-,methyl ester, 7,8,9-triacetate
[130525-58-5]
GLY003
Glycine, N-(1-oxobutyl)-, ethyl ester
[90205-46-2]
GLY004
Glycine, N-(2-cyanoethyl)-, ethyl ester
[44981-94-4]
GLY005
Glycine, N-phenyl-N-(phenylmethyl)-
[23582-63-0]
GLY006
Glycine, N-phenyl-N-(phenylmethyl)-, ethylester
[49790-83-2]
GLY008
Glycine, N-methyl-N-(phosphonomethyl)-
[24569-83-3]
GLY009
Glycine, N-(phosphonomethyl)-
[1071-83-6]
GLY014
D-glycero-D-galacto-Non-2-enonic acid,5-(acetylamino)-2,6-anhydro-4-azido-3,4,5-trideoxy-, methyl ester, 7-acetate
[1070897-55-0]
GLY016
D-glycero-Pentonic acid, 2-deoxy-2,2-difluoro-4,5-O-(1-methylethylidene)-, ethyl ester, (3)-
[928797-50-6]
GLY017
Glycine, N-[(3,5,7,12)-3,7,12-trihydroxy-24-oxocholan-24-yl]-, sodium salt, hydrate (1:1:?)
[338950-81-5]
GLY019
Glycine, (2S)-2-cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-2-cyclohexyl-, methyl ester, (2S)-
GLY020
Glycine, (2S)-2-cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-2-cyclohexyl-, (2S)-
[1033882-39-1]
GLY021
Glycine, L-2-cyclohexyl-N-[L-2-cyclohexyl-N-[(1,1-dimethylethoxy)carbonyl]glycyl]-, methyl ester
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. 
Page [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119]

 


New products

Copyright © 2010-2015 Fragmenta. All rights reserved.  Terms of Use | Order and Payment Terms | Help